美股A股
StockGist
Back
8-K2026-02-20· grok-4-1-fast-non-reasoning

BCTX · BriaCell Therapeutics Corp.

0001493152-26-007587

SEC filing

Summary

BriaCell Therapeutics Corp. announced on February 18, 2026, that it entered into an asset purchase agreement. The press release dated February 18, 2026, is attached as Exhibit 99.1 to the 8-K filing dated February 20, 2026.

Key takeaways